NCT02033980

Brief Summary

Recently, a new category classification (NICE classification) using non-magnified NBI has been proposed. We design this multicenter study to evaluate the reliability and validity of the NICE classification in diagnosing colorectal polyps by Chinese endoscopists during both image and real-time process.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
400

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2016

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 27, 2013

Completed
17 days until next milestone

First Posted

Study publicly available on registry

January 13, 2014

Completed
2.3 years until next milestone

Study Start

First participant enrolled

May 1, 2016

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2017

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2017

Completed
Last Updated

May 10, 2016

Status Verified

May 1, 2016

Enrollment Period

1.1 years

First QC Date

December 27, 2013

Last Update Submit

May 8, 2016

Conditions

Keywords

narrow band imaging(NBI)NICE classificationcolorectal lesionspredicting histology

Outcome Measures

Primary Outcomes (1)

  • Accuracy of NICE classification in histological prediction by gastroenterological fellows

    Diagnostic accuracy of gastroenterological fellows using non-magnified NBI according to NICE classification in histological prediction of polyps, compared with histologic examination

    within two weeks after polypectomy

Secondary Outcomes (1)

  • Diagnostic accuracy of high-definition and magnifying NBI for type 2 and type 3 lesions.

    two weeks after endoscopical or surgical resection

Study Arms (1)

colorectal lesions

OTHER

All lesions will be observed with NBI and removed endoscopically or surgically for histological diagnosis.

Device: NBI

Interventions

NBIDEVICE

All detected colorectal lesions will be examined by high-definition NBI. For type 2 and type 3 lesions, subsequent magnifying NBI examination will be performed.

Also known as: Evis Lucera system (CV-260, Olympus Inc, Japan), high-definition colonoscopes (CF-H260AL, Olympus Inc, Japan), magnifying colonoscopes (CF-H260AZL, Olympus Inc, Japan)
colorectal lesions

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with colorectal lesions during colonoscopy examination
  • Informed consent available

You may not qualify if:

  • Suspect of advanced colorectal cancer
  • History of colorectal surgery, familial adenomatous polyposis or inflammatory bowel disease
  • Poor bowel preparation
  • Patients under unsuitable conditions for examination or treatment, such as acute upper gastrointestinal bleeding, noncorrectable coagulopathy, severe systemic disease, etc

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ren Ji Hospital, School of Medicine, Shanghai Jiaotong University

Shanghai, 200001, China

RECRUITING

Related Publications (1)

  • Zhang QW, Zhang JJ, Yang AM, Sheng JQ, Liu YL, Li ZS, Chen HY, Feng N, Jiang QW, Jin P, Zhang LM, Fu HY, Gao YJ, Ge ZZ, Li XB. Feasibility of using narrow band imaging international colorectal endoscopic classification for diagnosing colorectal neoplasia in China: A multicenter pilot observational study. J Dig Dis. 2020 Feb;21(2):88-97. doi: 10.1111/1751-2980.12841.

Study Officials

  • Zhizheng Ge, MD,Ph.D

    Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai ,China.

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Zhizheng Ge, MD,Ph.D

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Ren Ji Hospital, School of medicine, Shanghai Jiao Tong University

Study Record Dates

First Submitted

December 27, 2013

First Posted

January 13, 2014

Study Start

May 1, 2016

Primary Completion

June 1, 2017

Study Completion

August 1, 2017

Last Updated

May 10, 2016

Record last verified: 2016-05

Locations